These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 8651343

  • 1. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma.
    Ikeda H, Hirato J, Akami M, Suzuki N, Takahashi A, Kuroiwa M, Matsuyama S.
    Am J Surg Pathol; 1996 Jun; 20(6):649-55. PubMed ID: 8651343
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma.
    Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, Takahashi A, Kuroiwa M.
    J Pediatr Surg; 1995 Jun; 30(6):805-8. PubMed ID: 7666311
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression.
    Koizumi H, Wakisaka M, Nakada K, Takakuwa T, Fujioka T, Yamate N, Uchikoshi T.
    Virchows Arch; 1995 Jun; 427(2):167-73. PubMed ID: 7582247
    [Abstract] [Full Text] [Related]

  • 4. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression.
    Oue T, Fukuzawa M, Kusafuka T, Kohmoto Y, Imura K, Nagahara S, Okada A.
    J Pediatr Surg; 1996 Feb; 31(2):251-7. PubMed ID: 8938353
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S, Chatten J, Hanada M, Reed JC.
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [Abstract] [Full Text] [Related]

  • 6. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
    Ekmekci S, Olgun N, Özer E.
    Turk Patoloji Derg; 2016 Jan; 32(2):99-104. PubMed ID: 27136108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K, Fujioka T, Kitagawa H, Takakuwa T, Yamate N.
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [Abstract] [Full Text] [Related]

  • 10. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
    Shen KL, Harn HJ, Ho LI, Yu CP, Chiu SC, Lee WH.
    Cancer; 1998 Jun 15; 82(12):2373-81. PubMed ID: 9635530
    [Abstract] [Full Text] [Related]

  • 11. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma.
    Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, Gadner H, Ambros PF.
    N Engl J Med; 1996 Jun 06; 334(23):1505-11. PubMed ID: 8618605
    [Abstract] [Full Text] [Related]

  • 12. DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.
    Melegh Z, Csernák E, Tóth E, Veleczki Z, Magyarosy E, Nagy K, Szentirmay Z.
    Virchows Arch; 2005 May 06; 446(5):517-24. PubMed ID: 15827757
    [Abstract] [Full Text] [Related]

  • 13. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S, Zaizen Y, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Ueda K, Tasaka H, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Yano H, Akiyama H, Ikeda K.
    J Pediatr Surg; 1996 Apr 06; 31(4):555-8. PubMed ID: 8801312
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors.
    Hachitanda Y, Nakagawara A, Nagoshi M, Tsuneyoshi M.
    Acta Pathol Jpn; 1992 Sep 06; 42(9):639-44. PubMed ID: 1476058
    [Abstract] [Full Text] [Related]

  • 15. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A, Matsuoka K, Okita H, Iwafuchi H, Hori H, Kumagai M.
    Pediatr Dev Pathol; 2011 Sep 06; 14(2):87-92. PubMed ID: 21288077
    [Abstract] [Full Text] [Related]

  • 16. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z, Bálint I, Tóth E, Csernák E, Szentirmay Z, Nagy K.
    Pediatr Pathol Mol Med; 2003 Sep 06; 22(3):213-22. PubMed ID: 12746172
    [Abstract] [Full Text] [Related]

  • 17. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
    Oppedal BR, Oien O, Jahnsen T, Brandtzaeg P.
    J Clin Pathol; 1989 Nov 06; 42(11):1148-52. PubMed ID: 2584426
    [Abstract] [Full Text] [Related]

  • 18. Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors.
    Fukushi D, Watanabe N, Kasai F, Haruta M, Kikuchi A, Kikuta A, Kato K, Nakadate H, Tsunematsu Y, Kaneko Y.
    Cancer Genet Cytogenet; 2009 Jan 01; 188(1):32-41. PubMed ID: 19061778
    [Abstract] [Full Text] [Related]

  • 19. Expression of bcl-2 gene product in neuroblastoma.
    Ramani P, Lu QL.
    J Pathol; 1994 Mar 01; 172(3):273-8. PubMed ID: 8195931
    [Abstract] [Full Text] [Related]

  • 20. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
    Bourhis J, Dominici C, McDowell H, Raschella G, Wilson G, Castello MA, Plouvier E, Lemerle J, Riou G, Bénard J.
    J Clin Oncol; 1991 Aug 01; 9(8):1371-5. PubMed ID: 2072140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.